These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9595729)

  • 1. [Early luminal diameter reduction after coronary angioplasty and its relation to the restenosis phenomenon].
    Caixeta AM; de Brito Júnior FS; Horta PE; Rati M; Fonseca M; Fukushima JT; Arie S; Pileggi F
    Arq Bras Cardiol; 1997 Sep; 69(3):175-9. PubMed ID: 9595729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic risk factors of luminal narrowing after coronary balloon angioplasty using balloon measurements to reflect stretch and elastic recoil at the dilation site. The CARPORT Study Group.
    Rensing BJ; Hermans WR; Vos J; Beatt KJ; Bossuyt P; Rutsch W; Serruys PW
    Am J Cardiol; 1992 Mar; 69(6):584-91. PubMed ID: 1536105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and angiographic predictors of immediate recoil after successful coronary angioplasty and relation to late restenosis.
    Rozenman Y; Gilon D; Welber S; Sapoznikov D; Gotsman MS
    Am J Cardiol; 1993 Nov; 72(14):1020-5. PubMed ID: 8213581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of high insufflation pressures on elastic recoil forces and vascular resistance after balloon dilatation].
    Hering D; Haude M; Caspari G; Baumgart D; Erbel R
    Z Kardiol; 1996 Apr; 85(4):273-80. PubMed ID: 8693770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of elastic recoil on restenosis after successful coronary angioplasty in unstable angina pectoris.
    Ardissino D; Di Somma S; Kubica J; Barberis P; Merlini PA; Eleuteri E; De Servi S; Bramucci E; Specchia G; Montemartini C
    Am J Cardiol; 1993 Mar; 71(8):659-63. PubMed ID: 8447261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Vatne K; Hansen J; Webb J; Buller C; Goulet G; Erikssen J; Thaulow E
    J Am Coll Cardiol; 2000 Mar; 35(3):592-9. PubMed ID: 10716459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty.
    Schmitz HJ; Erbel R; Meyer J; von Essen R
    Am Heart J; 1996 May; 131(5):884-91. PubMed ID: 8615306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Major dissection after PTCA is a strong independent predictor of early luminal deterioration].
    Gai L; Wang J; Huang D
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):509-12. PubMed ID: 11798809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24 hours after successful PTCA.
    Rodriguez AE; Santaera O; Larribau M; Fernandez M; Sarmiento R; Perez Baliño ; Newell JB; Roubin GS; Palacios IF
    Circulation; 1995 Mar; 91(5):1397-402. PubMed ID: 7867179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of balloon size and stenosis morphology on immediate and delayed elastic recoil after percutaneous transluminal coronary angioplasty.
    Hanet C; Wijns W; Michel X; Schroeder E
    J Am Coll Cardiol; 1991 Aug; 18(2):506-11. PubMed ID: 1856419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic analysis of immediate and long-term results of PTCR vs. PTCA in complex lesions (COBRA study).
    Dietz U; Rupprecht HJ; Ekinci O; Dill T; Erbel R; Kuck KH; Abdollahnia R; Rippin G; Meyer J; Hamm C
    Catheter Cardiovasc Interv; 2001 Jul; 53(3):359-67. PubMed ID: 11458414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastic recoil following percutaneous transluminal coronary angioplasty and Palmaz-Schatz stent implantation.
    Somitsu Y; Ikari Y; Ui K; Nakamura M; Hara K; Saeki F; Degawa T; Tamura T; Yabuki S; Yamaguchi T
    J Invasive Cardiol; 1995; 7(6):165-72. PubMed ID: 10155101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.